Rakesh Tailor

  • ▸ CEO, Contura International
  • ▸ Rakesh led Contura’s global success of Bulkamid® for the treatment of stress urinary incontinence (SUI) and its sale to Axonics Modulation Technologies for US$200 million in February 2021.